Search results
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead...
Benzinga· 2 days agoStrasbourg, France, June 3, 2024, 7:30 a.m. CET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the ...